Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)

Diabetes Technology& Therapeutics , Vol. 0, No. 0.

Source: Diabetes Technology - December 7, 2016 Category: Endocrinology Authors: Susanne Famulla Thomas R. Pieber Jens Eilbracht Dietmar Neubacher Nima Soleymanlou Hans J. Woerle Uli C. Broedl Stefan Kaspers Source Type: research